Biodesix (NASDAQ:BDSX) Earns Outperform Rating from William Blair
Biodesix (NASDAQ:BDSX – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at William Blair in a research report issued to clients and investors on Tuesday,RTT News reports. William Blair also issued estimates for Biodesix’s Q1 2026 earnings at ($0.05) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) […]
Biodesix (NASDAQ:BDSX – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at William Blair in a research report issued to clients and investors on Tuesday,RTT News reports. William Blair also issued estimates for Biodesix’s Q1 2026 earnings at ($0.05) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) […]
